QI LU
Live / Registered — Registered — Section 71 accepted (as of 30 Dec 2021)
What this means for you
Registered since 19 Apr 2011. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79076475
- Registration number
- 3946913
- Mark type
- Design + words
- Filed
- 26 Nov 2009
- Published for opposition
- 01 Feb 2011
- Registered
- 19 Apr 2011
- Attorney of record
- Dana Stewart-Mekdara
Goods and services
- Class 005 — Pharmaceuticals: [ Pharmaceutical preparations, namely, injections, capsules and tablets for use in ophthalmology, oncology, and chemotherapy; pharmaceutical preparations, namely, injections, capsules and tablets for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; pharmaceutical preparations, namely, injections, capsules and tablets for the treatment of diseases and disorders in the gastrointestinal system, endocrine system and psychiatric system; pharmaceutical preparations, namely, injections, capsules and tablets for the treatment of inflammation; ] biomedical medicines for use in ophthalmology, oncology and chemotherapy; [ biomedical medicines for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; biomedical medicines for the treatment of diseases and disorders in the gastrointestinal system, endocrine system and psychiatric system; biomedical medicines for the treatment of inflammation; ] medicines for humans for use in ophthalmology, oncology and chemotherapy; [ medicines for humans for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; medicines for humans for the treatment of gastrointestinal system, endocrine system and psychiatric system related diseases and disorders; medicines for humans for the treatment of inflammation; ] drugs for medical purposes for use in ophthalmology, oncology and chemotherapy [ ; drugs for medical purposes for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; drugs for medical purposes for the treatment of gastrointestinal system, endocrine system and psychiatric system related diseases and disorders; drugs for medical purposes, namely, the treatment of inflammation ]
Owner
- QILU PHARMACEUTICAL CO., LTD, Shandong, CN
- QILU PHARMACEUTICAL CO., LTD, CN
- QILU PHARMACEUTICAL CO., LTD, CN
Prosecution history
- 06 Nov 2022 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 26 Sept 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 26 Sept 2022 — INVALIDATION PROCESSED
- 30 Aug 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 30 Dec 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 30 Dec 2021 — REGISTERED-SEC.71 ACCEPTED
- 04 Nov 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Jun 2021 — TEAS SECTION 71 RECEIVED
- 10 Dec 2020 — CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
- 16 Oct 2020 — CORRECTION TRANSACTION RECEIVED FROM IB
- 28 Aug 2020 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 19 Apr 2020 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 12 Dec 2019 — INTERNATIONAL REGISTRATION RENEWED
- 25 Mar 2017 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 25 Mar 2017 — REGISTERED-SEC.71 ACCEPTED